Bernofsky C
Mol Cell Biochem. 1980 Dec 16;33(3):135-43. doi: 10.1007/BF00225285.
Tissue levels of NAD+ appear to be regulated primarily by the concentration of extracellular nicotinamide, which in turn is controlled by the liver in a hormone-sensitive manner. Hepatic regulation involves the conversion of excess serum nicotinamide to 'Storage NAD+' and inactive excretory products, and the replenishment of serum nicotinamide by the hydrolysis of 'Storage NAD+.' Tryptophan and nicotinic acid contribute to 'Storage NAD+,' and thus are additional sources of nicotinamide. In response to administered nicotinamide, there is a preferential utilization of ATP and PRPP (5-phosphorylribose-1-pyrophosphate) for the biosynthesis of NAD+. This biosynthetic priority, whose purpose appears to be the conservation of intracellular nicotinamide, may explain why nicotinamide inhibits RNA and DNA synthesis in regenerating tissues and why elevated nicotinamide levels are toxic to growing animals and to mammalian cells in culture.
NAD+的组织水平似乎主要由细胞外烟酰胺的浓度调节,而细胞外烟酰胺的浓度又由肝脏以激素敏感的方式控制。肝脏调节涉及将过量的血清烟酰胺转化为“储存NAD+”和无活性的排泄产物,以及通过“储存NAD+”的水解来补充血清烟酰胺。色氨酸和烟酸有助于形成“储存NAD+”,因此是烟酰胺的额外来源。给予烟酰胺后,ATP和PRPP(5-磷酸核糖-1-焦磷酸)会优先用于NAD+的生物合成。这种生物合成优先级的目的似乎是保护细胞内的烟酰胺,这可能解释了为什么烟酰胺会抑制再生组织中的RNA和DNA合成,以及为什么烟酰胺水平升高对生长中的动物和培养中的哺乳动物细胞有毒性。